Claudin-1-Dependent Destabilization of the Blood–Brain Barrier in Chronic Stroke
Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence h...
Saved in:
Published in | The Journal of neuroscience Vol. 39; no. 4; pp. 743 - 757 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Society for Neuroscience
23.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB “leakage“ found subacutely or chronically. The current study examined BBB structural alterations during the “BBB leakage” associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic
cis
- and
trans
-interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5
cis
- and
trans
-interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential “defect” in postischemic barrier formation that may underlie prolonged vessel leakiness.
SIGNIFICANCE STATEMENT
Although rarely expressed at the normal blood–brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke. |
---|---|
AbstractList | Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB "leakage" found subacutely or chronically. The current study examined BBB structural alterations during the "BBB leakage" associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic
- and
-interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5
- and
-interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential "defect" in postischemic barrier formation that may underlie prolonged vessel leakiness.
Although rarely expressed at the normal blood-brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke. Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB "leakage" found subacutely or chronically. The current study examined BBB structural alterations during the "BBB leakage" associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis- and trans-interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis- and trans-interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential "defect" in postischemic barrier formation that may underlie prolonged vessel leakiness.SIGNIFICANCE STATEMENT Although rarely expressed at the normal blood-brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke.Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB "leakage" found subacutely or chronically. The current study examined BBB structural alterations during the "BBB leakage" associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis- and trans-interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis- and trans-interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential "defect" in postischemic barrier formation that may underlie prolonged vessel leakiness.SIGNIFICANCE STATEMENT Although rarely expressed at the normal blood-brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke. Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB “leakage“ found subacutely or chronically. The current study examined BBB structural alterations during the “BBB leakage” associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis - and trans -interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis - and trans -interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential “defect” in postischemic barrier formation that may underlie prolonged vessel leakiness. SIGNIFICANCE STATEMENT Although rarely expressed at the normal blood–brain barrier (BBB), claudin-1 is expressed in pathological conditions. Analyzing poststroke human and mouse blood microvessels we have identified that claudin-1 is highly expressed in leaky brain microvessels. Our results reveal that claudin-1 is incorporated in BBB tight junction complex, impeding BBB recovery and causing BBB leakiness during poststroke recovery. Targeting claudin-1 with a claudin-1 peptide improves brain endothelial barrier permeability and consequently functional neurological recovery after stroke. Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence stroke recovery, increase the risk of repeat stroke, and be a solid substrate for developing vascular dementia. Although accumulating evidence has defined morphological alterations and underlying mechanisms of tight junction (TJ) changes during BBB breakdown in acute stroke, very little is known about the type of alterations and mechanisms in BBB “leakage“ found subacutely or chronically. The current study examined BBB structural alterations during the “BBB leakage” associated with the chronic phase of stroke in male mice and both genders of humans. We found significant upregulation of claudin-1 mRNA and protein, a nonspecific claudin for blood vessels, and downregulation in claudin-5 expression. Morphological and biochemical as well as fluorescence resonance energy transfer and fluorescence recovery after photobleaching analysis of postischemic brain endothelial cells and cells overexpressing claudin-1 indicated that newly synthesized claudin-1 was present on the cell membrane (∼45%), was incorporated into the TJ complex with established interaction with zonula occludens-1 (ZO-1), and was building homophilic cis- and trans-interactions. The appearance of claudin-1 in the TJ complex reduced claudin-5 strands (homophilic claudin-5 cis- and trans-interactions) and claudin-5/ZO-1 interaction affecting claudin-5 incorporation into the TJ complex. Moreover, claudin-1 induction was associated with an endothelial proinflammatory phenotype. Targeting claudin-1 with a specific C1C2 peptide improved brain endothelial barrier permeability and functional recovery in chronic stroke condition. This study highlights a potential “defect” in postischemic barrier formation that may underlie prolonged vessel leakiness. |
Author | Choi, Jennifer Hu, Anna Andjelkovic, Anuska V. Johnson, Allison M. Keep, Richard F. Sladojevic, Nikola Blasig, Ingolf E. Stamatovic, Svetlana M. Dithmer, Sophie |
Author_xml | – sequence: 1 givenname: Nikola surname: Sladojevic fullname: Sladojevic, Nikola – sequence: 2 givenname: Svetlana M. surname: Stamatovic fullname: Stamatovic, Svetlana M. – sequence: 3 givenname: Allison M. surname: Johnson fullname: Johnson, Allison M. – sequence: 4 givenname: Jennifer surname: Choi fullname: Choi, Jennifer – sequence: 5 givenname: Anna surname: Hu fullname: Hu, Anna – sequence: 6 givenname: Sophie surname: Dithmer fullname: Dithmer, Sophie – sequence: 7 givenname: Ingolf E. surname: Blasig fullname: Blasig, Ingolf E. – sequence: 8 givenname: Richard F. orcidid: 0000-0001-6441-5334 surname: Keep fullname: Keep, Richard F. – sequence: 9 givenname: Anuska V. orcidid: 0000-0001-8365-8016 surname: Andjelkovic fullname: Andjelkovic, Anuska V. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30504279$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkd1O3DAQha2Kqiy0r4AiccNNFv87kRASm6UtFQIJyrVl4knXkLUXJ6lUrniHvmGfBKf8CLjhyiPNN8dn5mygNR88ILRF8JQIynZ_nBxenJ2eV0dTwhnNSTGlmBQf0CR1y5xyTNbQBFOFc8kVX0cbXXeFMVaYqE9onWGBOVXlBJ1VrRms8znJ57ACb8H32Ry63ly61t2a3gWfhSbrF5DN2hDsv7u_s2icz2YmRgcxS2W1iMG7OjvvY7iGz-hjY9oOvjy-m-ji6-HP6nt-fPrtqDo4zmuBiz5XDbVYcAFFKRrVcAoKhCgtZQxUUytlC0KASMpko0RtLDdWUlGWVElujWSbaP9BdzVcLsHWyXk0rV5FtzTxjw7G6dcd7xb6V_itJeNM8lFg51Eghpsh7ayXrquhbY2HMHSaEl5iwpjiCd1-g16FIfq0XqIUTRAVo-DWS0fPVp7OnYC9B6COoesiNLp2_f8bJ4Ou1QTrMV39nK4e09Wk0GO6aVy-GX_64Z3BexPDqe8 |
CitedBy_id | crossref_primary_10_1016_j_biopha_2023_115272 crossref_primary_10_1080_21688370_2025_2470482 crossref_primary_10_3389_fneur_2020_594672 crossref_primary_10_47093_2218_7332_2021_12_4_39_50 crossref_primary_10_1016_j_jss_2024_06_007 crossref_primary_10_14336_AD_2022_0212 crossref_primary_10_3390_ijms21020569 crossref_primary_10_3390_ijms24129784 crossref_primary_10_6061_clinics_2021_e2167 crossref_primary_10_1038_s41385_022_00550_7 crossref_primary_10_3390_ijms22041512 crossref_primary_10_1016_j_mvr_2020_104059 crossref_primary_10_1007_s11046_022_00653_6 crossref_primary_10_1186_s12987_020_00192_6 crossref_primary_10_1515_revneuro_2020_0067 crossref_primary_10_1007_s10571_023_01437_2 crossref_primary_10_1016_j_bbi_2023_07_009 crossref_primary_10_3390_ijms20215372 crossref_primary_10_1007_s12035_024_03939_6 crossref_primary_10_1016_j_addr_2023_114820 crossref_primary_10_2174_1570159X18666200720173316 crossref_primary_10_1186_s12987_024_00563_3 crossref_primary_10_1007_s12035_023_03655_7 crossref_primary_10_1186_s12987_020_00181_9 crossref_primary_10_1172_jci_insight_168475 crossref_primary_10_3390_ijms25053065 crossref_primary_10_1139_bcb_2023_0047 crossref_primary_10_1016_j_biomaterials_2025_123138 crossref_primary_10_1016_j_brainresbull_2022_09_017 crossref_primary_10_1016_j_drudis_2020_05_007 crossref_primary_10_1186_s12987_022_00371_7 crossref_primary_10_1016_j_bbamem_2020_183298 crossref_primary_10_1186_s12974_020_01946_7 crossref_primary_10_1038_s41598_023_49861_0 crossref_primary_10_3389_fphar_2021_748568 crossref_primary_10_1016_j_atherosclerosis_2025_119149 crossref_primary_10_1016_j_jep_2023_117700 crossref_primary_10_1038_s41420_021_00773_w crossref_primary_10_1016_j_nbd_2023_106277 crossref_primary_10_3389_fncel_2022_931247 crossref_primary_10_1007_s00221_025_07018_7 crossref_primary_10_1016_j_immuni_2024_12_008 crossref_primary_10_1111_cns_13561 crossref_primary_10_1186_s12987_022_00386_0 crossref_primary_10_3390_ijms241512034 crossref_primary_10_1007_s12033_023_00835_7 crossref_primary_10_3390_cells10112997 crossref_primary_10_1016_j_intimp_2023_109850 crossref_primary_10_1039_D4SD00063C crossref_primary_10_1007_s10456_021_09796_4 crossref_primary_10_3389_fddev_2022_1027098 crossref_primary_10_3390_jcm14020386 crossref_primary_10_1186_s12986_022_00675_3 crossref_primary_10_1007_s12035_022_02761_2 crossref_primary_10_1017_S1431927620020942 crossref_primary_10_3390_ijms241612689 crossref_primary_10_1021_acsnano_1c08432 crossref_primary_10_1080_1028415X_2021_1889452 crossref_primary_10_1186_s12987_019_0124_y crossref_primary_10_3390_ijms232112781 crossref_primary_10_1016_j_bbi_2021_05_011 crossref_primary_10_3389_fcimb_2021_647048 crossref_primary_10_1177_15357597221127164 crossref_primary_10_3389_fimmu_2022_796288 crossref_primary_10_1007_s11011_021_00694_8 crossref_primary_10_17816_onco636917 crossref_primary_10_1186_s12987_020_00202_7 crossref_primary_10_25692_ACEN_2021_2_1 crossref_primary_10_1097_WNR_0000000000002098 crossref_primary_10_3389_fnmol_2021_752781 crossref_primary_10_1016_j_jneuroim_2021_577763 crossref_primary_10_3390_biomedicines10081792 crossref_primary_10_2745_dds_34_374 crossref_primary_10_1248_bpb_b21_00408 crossref_primary_10_1016_j_pharmthera_2023_108541 crossref_primary_10_1038_s41419_019_1771_2 crossref_primary_10_1186_s12974_023_02908_5 crossref_primary_10_3390_pharmaceutics13111980 crossref_primary_10_1016_j_prp_2023_155085 crossref_primary_10_1161_ATVBAHA_119_312816 crossref_primary_10_3390_ohbm5020016 crossref_primary_10_1080_21688370_2021_1926190 crossref_primary_10_3389_fncel_2020_540669 crossref_primary_10_1186_s12987_020_00179_3 crossref_primary_10_1039_D1FO00155H crossref_primary_10_1007_s12035_021_02654_w crossref_primary_10_3390_nu14091698 crossref_primary_10_1016_j_jmb_2020_02_034 crossref_primary_10_1177_0271678X241299960 crossref_primary_10_3390_ijms23147813 crossref_primary_10_1038_s41598_025_93756_1 crossref_primary_10_1186_s12987_023_00414_7 crossref_primary_10_3390_cells10040963 |
Cites_doi | 10.1083/jcb.201412147 10.1159/000336116 10.1016/j.biomaterials.2015.03.007 10.1007/BF02634568 10.1186/s12979-015-0029-9 10.1016/j.expneurol.2009.06.002 10.1523/JNEUROSCI.5977-11.2012 10.1038/nm.3363 10.1016/j.nbd.2009.07.030 10.1002/jcp.20823 10.1523/JNEUROSCI.20-23-j0004.2000 10.1016/S0028-3908(00)00003-4 10.1096/fj.13-248880 10.1016/j.neulet.2008.08.082 10.1161/STROKEAHA.110.608257 10.1083/jcb.147.4.891 10.1038/jcbfm.2011.79 10.1080/21688370.2016.1154641 10.1161/STROKEAHA.110.611731 10.1186/s12974-017-0933-3 10.1172/JCI91301 10.1016/j.nbd.2014.03.010 10.1038/sj.jcbfm.9600229 10.1161/01.STR.0000250235.80253.e9 10.1096/fj.07-8319com 10.2174/092986708783330665 10.1016/S0166-2236(99)01401-0 10.1038/jcbfm.2014.199 10.1016/0361-9230(80)90166-5 10.1042/BJ20150148 10.1083/jcb.200302070 10.1038/ncomms12276 10.1007/s004010000180 10.1001/archinte.160.21.3196 10.1124/pr.57.2.4 10.1007/s00401-011-0883-2 10.1016/j.brainres.2009.05.025 10.1146/annurev-physiol-030212-183809 10.1042/BJ20140431 10.1016/j.neuroscience.2008.02.012 |
ContentType | Journal Article |
Copyright | Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0. Copyright Society for Neuroscience Jan 23, 2019 Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0 2019 |
Copyright_xml | – notice: Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0. – notice: Copyright Society for Neuroscience Jan 23, 2019 – notice: Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
DOI | 10.1523/JNEUROSCI.1432-18.2018 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts Animal Behavior Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1529-2401 |
EndPage | 757 |
ExternalDocumentID | PMC6343646 30504279 10_1523_JNEUROSCI_1432_18_2018 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: RF1 AG057928 – fundername: NINDS NIH HHS grantid: R21 NS098211 – fundername: NINDS NIH HHS grantid: R01 NS062853 – fundername: NINDS NIH HHS grantid: R21 NS098066 – fundername: NINDS NIH HHS grantid: R56 NS062853 |
GroupedDBID | --- -DZ -~X .55 18M 2WC 34G 39C 53G 5GY 5RE 5VS AAFWJ AAJMC AAYXX ABBAR ABIVO ACGUR ACNCT ADBBV ADCOW ADHGD AENEX AFCFT AFOSN AFSQR AHWXS ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD F5P GX1 H13 HYE H~9 KQ8 L7B OK1 P0W P2P QZG R.V RHI RPM TFN TR2 W8F WH7 WOQ X7M YBU YHG YKV YNH YSK AFHIN AIZTS CGR CUY CVF ECM EIF NPM RHF 7QG 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
ID | FETCH-LOGICAL-c508t-7f2d0545e895f7f42e7e559d233e7fc77d811e16236f75cad4ad625992764da63 |
ISSN | 0270-6474 1529-2401 |
IngestDate | Thu Aug 21 13:52:28 EDT 2025 Fri Jul 11 05:48:36 EDT 2025 Mon Jun 30 16:40:56 EDT 2025 Wed Feb 19 02:30:39 EST 2025 Tue Jul 01 04:15:40 EDT 2025 Thu Apr 24 23:03:31 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | cerebrovascular injury claudin-1 BBB recovery stroke |
Language | English |
License | https://creativecommons.org/licenses/by-nc-sa/4.0 Copyright © 2019 the authors 0270-6474/19/390743-15$15.00/0. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c508t-7f2d0545e895f7f42e7e559d233e7fc77d811e16236f75cad4ad625992764da63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 N. Sladojevic's present address: Department of Medicine, Section of Cardiology, University of Chicago, Chicago IL, 60637. Author contributions: N.S., S.M.S., I.E.B., and R.F.K. edited the paper; A.V.A. wrote the first draft of the paper. R.F.K. and A.V.A. designed research; N.S., S.M.S., A.M.J., J.C., A.H., and A.V.A. performed research; S.D. and I.E.B. contributed unpublished reagents/analytic tools; N.S., S.M.S., A.M.J., J.C., A.H., and A.V.A. analyzed data; N.S., R.F.K., and A.V.A. wrote the paper. |
ORCID | 0000-0001-6441-5334 0000-0001-8365-8016 |
OpenAccessLink | https://www.jneurosci.org/content/jneuro/39/4/743.full.pdf |
PMID | 30504279 |
PQID | 2172133256 |
PQPubID | 2049535 |
PageCount | 15 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6343646 proquest_miscellaneous_2149013374 proquest_journals_2172133256 pubmed_primary_30504279 crossref_citationtrail_10_1523_JNEUROSCI_1432_18_2018 crossref_primary_10_1523_JNEUROSCI_1432_18_2018 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-01-23 |
PublicationDateYYYYMMDD | 2019-01-23 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-23 day: 23 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Baltimore |
PublicationTitle | The Journal of neuroscience |
PublicationTitleAlternate | J Neurosci |
PublicationYear | 2019 |
Publisher | Society for Neuroscience |
Publisher_xml | – name: Society for Neuroscience |
References | 2023041803343637000_39.4.743.1 2023041803343637000_39.4.743.15 2023041803343637000_39.4.743.37 2023041803343637000_39.4.743.16 2023041803343637000_39.4.743.38 2023041803343637000_39.4.743.13 2023041803343637000_39.4.743.35 2023041803343637000_39.4.743.14 2023041803343637000_39.4.743.36 2023041803343637000_39.4.743.5 2023041803343637000_39.4.743.19 2023041803343637000_39.4.743.4 2023041803343637000_39.4.743.3 2023041803343637000_39.4.743.17 2023041803343637000_39.4.743.39 2023041803343637000_39.4.743.2 2023041803343637000_39.4.743.18 2023041803343637000_39.4.743.30 2023041803343637000_39.4.743.11 2023041803343637000_39.4.743.33 2023041803343637000_39.4.743.12 2023041803343637000_39.4.743.34 2023041803343637000_39.4.743.31 2023041803343637000_39.4.743.10 2023041803343637000_39.4.743.32 2023041803343637000_39.4.743.9 2023041803343637000_39.4.743.8 2023041803343637000_39.4.743.7 2023041803343637000_39.4.743.6 2023041803343637000_39.4.743.26 2023041803343637000_39.4.743.27 2023041803343637000_39.4.743.24 2023041803343637000_39.4.743.25 2023041803343637000_39.4.743.28 2023041803343637000_39.4.743.29 2023041803343637000_39.4.743.40 2023041803343637000_39.4.743.22 2023041803343637000_39.4.743.23 2023041803343637000_39.4.743.20 2023041803343637000_39.4.743.21 |
References_xml | – ident: 2023041803343637000_39.4.743.37 doi: 10.1083/jcb.201412147 – ident: 2023041803343637000_39.4.743.4 doi: 10.1159/000336116 – ident: 2023041803343637000_39.4.743.33 doi: 10.1016/j.biomaterials.2015.03.007 – ident: 2023041803343637000_39.4.743.18 doi: 10.1007/BF02634568 – ident: 2023041803343637000_39.4.743.10 doi: 10.1186/s12979-015-0029-9 – ident: 2023041803343637000_39.4.743.2 doi: 10.1016/j.expneurol.2009.06.002 – ident: 2023041803343637000_39.4.743.11 doi: 10.1523/JNEUROSCI.5977-11.2012 – ident: 2023041803343637000_39.4.743.14 doi: 10.1038/nm.3363 – ident: 2023041803343637000_39.4.743.1 doi: 10.1016/j.nbd.2009.07.030 – ident: 2023041803343637000_39.4.743.26 doi: 10.1002/jcp.20823 – ident: 2023041803343637000_39.4.743.7 doi: 10.1523/JNEUROSCI.20-23-j0004.2000 – ident: 2023041803343637000_39.4.743.8 doi: 10.1016/S0028-3908(00)00003-4 – ident: 2023041803343637000_39.4.743.22 doi: 10.1096/fj.13-248880 – ident: 2023041803343637000_39.4.743.31 doi: 10.1016/j.neulet.2008.08.082 – ident: 2023041803343637000_39.4.743.40 doi: 10.1161/STROKEAHA.110.608257 – ident: 2023041803343637000_39.4.743.13 doi: 10.1083/jcb.147.4.891 – ident: 2023041803343637000_39.4.743.17 doi: 10.1038/jcbfm.2011.79 – ident: 2023041803343637000_39.4.743.34 doi: 10.1080/21688370.2016.1154641 – ident: 2023041803343637000_39.4.743.36 doi: 10.1161/STROKEAHA.110.611731 – ident: 2023041803343637000_39.4.743.38 doi: 10.1186/s12974-017-0933-3 – ident: 2023041803343637000_39.4.743.16 doi: 10.1172/JCI91301 – ident: 2023041803343637000_39.4.743.32 doi: 10.1016/j.nbd.2014.03.010 – ident: 2023041803343637000_39.4.743.5 doi: 10.1038/sj.jcbfm.9600229 – ident: 2023041803343637000_39.4.743.3 doi: 10.1161/01.STR.0000250235.80253.e9 – ident: 2023041803343637000_39.4.743.28 doi: 10.1096/fj.07-8319com – ident: 2023041803343637000_39.4.743.39 doi: 10.2174/092986708783330665 – ident: 2023041803343637000_39.4.743.6 doi: 10.1016/S0166-2236(99)01401-0 – ident: 2023041803343637000_39.4.743.20 doi: 10.1038/jcbfm.2014.199 – ident: 2023041803343637000_39.4.743.25 doi: 10.1016/0361-9230(80)90166-5 – ident: 2023041803343637000_39.4.743.23 doi: 10.1042/BJ20150148 – ident: 2023041803343637000_39.4.743.24 doi: 10.1083/jcb.200302070 – ident: 2023041803343637000_39.4.743.30 doi: 10.1038/ncomms12276 – ident: 2023041803343637000_39.4.743.21 doi: 10.1007/s004010000180 – ident: 2023041803343637000_39.4.743.12 doi: 10.1001/archinte.160.21.3196 – ident: 2023041803343637000_39.4.743.15 doi: 10.1124/pr.57.2.4 – ident: 2023041803343637000_39.4.743.27 doi: 10.1007/s00401-011-0883-2 – ident: 2023041803343637000_39.4.743.9 doi: 10.1016/j.brainres.2009.05.025 – ident: 2023041803343637000_39.4.743.19 doi: 10.1146/annurev-physiol-030212-183809 – ident: 2023041803343637000_39.4.743.29 doi: 10.1042/BJ20140431 – ident: 2023041803343637000_39.4.743.35 doi: 10.1016/j.neuroscience.2008.02.012 |
SSID | ssj0007017 |
Score | 2.5702672 |
Snippet | Recent evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence... Recent evidence suggests that blood-brain barrier (BBB) recovery and reestablishment of BBB impermeability after stroke is incomplete. This could influence... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 743 |
SubjectTerms | Animals Barriers Blood vessels Blood-brain barrier Blood-Brain Barrier - pathology Brain Brain Ischemia - pathology Cell membranes Claudin-1 - genetics Claudin-5 - biosynthesis Claudin-5 - genetics Dementia disorders Destabilization Down-Regulation - genetics Endothelial cells Endothelial Cells - pathology Energy recovery Energy transfer Female Fluorescence Fluorescence recovery after photobleaching Fluorescence resonance energy transfer Health risks Humans Infarction, Middle Cerebral Artery - genetics Infarction, Middle Cerebral Artery - pathology Inflammation Inflammation - pathology Leakage Male Mice Morphology mRNA Permeability Phenotypes Photobleaching Proteins Recovery of function Stroke Stroke - genetics Stroke - pathology Substrates Tight Junctions - pathology Vascular dementia Zonula occludens-1 protein Zonula Occludens-1 Protein - biosynthesis Zonula Occludens-1 Protein - genetics |
Title | Claudin-1-Dependent Destabilization of the Blood–Brain Barrier in Chronic Stroke |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30504279 https://www.proquest.com/docview/2172133256 https://www.proquest.com/docview/2149013374 https://pubmed.ncbi.nlm.nih.gov/PMC6343646 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgvPCCgHEJDBQkxAsKW2wnTh5Ht2kboyC1lfpmObYjxkKCIEViv57jS910q8TgJYrspK58vhx_xz4XhF5ne6JQkpCEKl0lVJZVItIKJzQTuk6xEtjm6f44zo9n9HSezVcb-ja6pK_eycuNcSX_I1VoA7maKNl_kGz4UWiAe5AvXEHCcL2RjEeNWMDaA_bZga9l2781hqTNmnsZyKD1AbAO6u9NQQhzxmDr1JmAP5cb1xxOdxdrXkGrmDHLVgd5LwMUJo1Q3VdYWaXD1EXXBCUPJBa4cOf7Jr9034hWrPZefWUuF2PT2DqIA1eD7nzoeTPcmTDBUGnigoeXyhTb0xuHHb2hzWtgl87II40O1ClzKZyuqfnMpps4HRtvx8noBNQ9wUlqPfWK1cK2PMwff-JHs7MzPj2cT2-jOxgMClPr4uDkQ1iz2Z6tzRz-nY8lh3F2N4-yTmOu2SZXXWwHnGV6H93z4ov3HXIeoFu6fYi291sQzLff8ZvYuv_ac5Vt9HkDmOIrYIq7OgYwxQMwxR5MMdx6MMUOTI_Q7OhwOjpOfLmNRAJL7xNWYwUEPtNFmdWsplgzDfamwoRoVkvGVJGmOgW-nNcsk0JRoYz1XGKWUyVy8hhttV2rnxp_uRx4fp2VssC0kFVVKVyoUpNcSphiEqFsOXtc-lz0piRKw41NCrPOw6xzM-s8LbiZ9Qjthve-u2wsf31jZykc7r_cn9wUZUsJAbYfoVehG_SqOSwTre4W5hkKVJkQRiP0xMkyDAlrpClRU0aIrUk5PGBytq_3tOdfbO72nFCS0_zZDcZ9ju6uvqodtNX_WOgXwID76qUF7x8g6bAG |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Claudin-1-Dependent+Destabilization+of+the+Blood-Brain+Barrier+in+Chronic+Stroke&rft.jtitle=The+Journal+of+neuroscience&rft.au=Sladojevic%2C+Nikola&rft.au=Stamatovic%2C+Svetlana+M&rft.au=Johnson%2C+Allison+M&rft.au=Choi%2C+Jennifer&rft.date=2019-01-23&rft.issn=1529-2401&rft.eissn=1529-2401&rft.volume=39&rft.issue=4&rft.spage=743&rft_id=info:doi/10.1523%2FJNEUROSCI.1432-18.2018&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon |